Delivery Order SPE2DB22D2211-SPE2DB25FSCEV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of BIKTARVY 50-200-25 mg tablets (30-count units) with a ceiling value of $11,939.20. This competitively awarded, firm fixed-price delivery order is non-set-aside and carries an ultimate completion date of June 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor within the federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $31,805.90 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for ultimate completion on June 3, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units, valued at $17,229.27. This firm fixed price delivery order, with an ultimate completion date of August 26, 2025, represents a competitively awarded contract with no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and the contract falls under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This contract, valued at approximately $76.4K, represents a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. The order is scheduled for ultimate completion by September 4, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 3, 2025, for the supply of BIKTARVY 50-200-25 mg tablets (30-count units) valued at $37,471.88. This competitively awarded, firm fixed-price delivery order, with a completion date of July 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $5,213.80 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) valued at $141,757, with a firm fixed price structure and no set-aside designation. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under a larger contracting vehicle supporting the...
- The Defense Logistics Agency awarded a $37,967.82 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in packages of 30 units. This delivery order, which is a child contract under a larger vehicle, requires completion by September 4, 2025, and was competitively awarded without set-aside provisions. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This firm fixed price delivery order carries a ceiling value of $35,801.35 and is scheduled for ultimate completion by July 24, 2025. The award represents a non-competitive procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral...
- The Defense Logistics Agency awarded a delivery order valued at $3,725.92 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 12, 2025, represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. BIKTARVY is an antiretroviral medication used in HIV treatment, reflecting the breadth...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCEVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units, valued at $2,232.63. This firm fixed-price delivery order, which is due for completion by August 6, 2025, represents a non-set-aside competitive award. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The parent IDC enables the company to supply an extensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for BIKTARVY, an antiretroviral medication, exemplifies the company's role in fulfilling critical medical supply needs across the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/5/25 |